12 results
8-K
EX-99.1
ARCT
Arcturus Therapeutics Holdings Inc
9 May 23
Arcturus Therapeutics Announces First Quarter 2023 Financial Update and Pipeline Progress
4:11pm
the recruitment target and completed administration in a Phase 1 single ascending dosing study with 32 healthy participants (8 subjects per cohort). The safety
10-K
5yem7x gk
16 Mar 20
Annual report
11:09am
424B3
o8edzr9
12 Apr 19
Prospectus supplement
4:39pm
S-4/A
6kwye45 nv8mah16dj
11 Apr 19
Registration of securities issued in business combination transactions (amended)
5:26pm
S-4
7g8cc
15 Mar 19
Registration of securities issued in business combination transactions
9:35pm
- Prev
- 1
- Next